Skip to main content
logo
IRLAB Therapeutics AB (publ) (STO:IRLAB.A)
Sweden flag Sweden · Delayed Price · Currency is SEK
1.268
+0.030 (2.42%)
At close: Jun 11, 2026

IRLAB Therapeutics AB Revenue

IRLAB Therapeutics AB had revenue of 39.36M SEK in the quarter ending March 31, 2026, with 802.75% growth. This brings the company's revenue in the last twelve months to 92.46M, down -6.59% year-over-year. In the year 2025, IRLAB Therapeutics AB had annual revenue of 57.46M, down -39.28%.

Revenue (ttm)
92.46M
Revenue Growth
-6.59%
P/S Ratio
1.16
Revenue / Employee
2.98M
Employees
31
Market Cap
107.70M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202557.46M-37.17M-39.28%
Dec 31, 202494.63M88.95M1,566.57%
Dec 31, 20235.68M-55.46M-90.71%
Dec 31, 202261.14M-146.65M-70.58%
Dec 31, 2021207.78M207.48M69,160.67%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Alzinova AB25.66M
Scandinavian ChemoTech AB12.61M
Biovica International AB10.93M
AcouSort AB10.05M
NextCell Pharma AB9.24M
Spago Nanomedical AB4.38M
Simris Group AB (PUBL)2.65M
Pila Pharma AB1.13M
Revenue Rankings

IRLAB Therapeutics AB News

More News